The Journal of Headache and Pain is a peer-reviewed open access journal specifically dedicated to researchers involved in all aspects of headache and related pain syndromes, including epidemiology, public health, basic science, translational medicine, clinical trials and real-world data. With a multidisciplinary perspective, The Journal of Headache and Pain covers headache medicine and related pain syndromes in all medical disciplines and particularly encourages clinical, translational and basic science submissions in the areas of pain management, genetics, neurology and internal medicine. Read more.
Aims and scope
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
The Greppi Award 2021
Submissions should be made to The Journal of Headache and Pain between 1 March - 30 April 2021 flagging the Greppi Award option as article type.
The Italian Society for the Study of Headaches (SISC) announces the competition of the Enrico Greppi Award 2021 – 22nd Edition. The award will be granted to the best unpublished original paper dealing with clinical, epidemiological, genetic, pathophysiological or therapeutic aspects of headache. The prize amounts to € 5,000 and is open to researchers of all nationalities. The 2021 Award is endorsed by the European Headache Federation (EHF). The winner will be invited to present the paper at The International Headache Congress, to be held in Berlin on 8-12 September 2021.
Click here to see Q&As with the authors of the journal's most highly viewed articles!
Click here to view which articles were talked about the most in 2019!
Editorial | 21 February 2018
Migraine is first cause of disability in under 50s: will health politicians now take notice?
Timothy J. Steiner, Lars J. Stovner, Theo Vos, R. Jensen and Z. Katsarava
Research | 05 February 2018
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
Andrew M. Blumenfeld, Richard J. Stark, Marshall C. Freeman, Amelia Orejudos and Aubrey Manack Adams
Consensus article | 16 January 2019
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas and Paolo Martelletti
Research | 01 February 2018
Poor medical care for people with migraine in Europe – evidence from the Eurolight study
Zaza Katsarava, Maka Mania, Christian Lampl, Johanna Herberhold and Timothy J. Steiner
Review | 12 March 2018
The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system
Review | 09 March 2018
PACAP and its role in primary headaches
Lars Edvinsson, János Tajti, Levente Szalárdy and László Vécsei
Review | 07 August 2018
PACAP38 and PAC1 receptor blockade: a new target for headache?
Eloisa Rubio-Beltrán, Edvige Correnti, Marie Deen, Katharina Kamm, Tim Kelderman, Laura Papetti, Simone Vigneri, Antoinette MaassenVanDenBrink and Lars Edvinsson
Research | 24 May 2018
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Eric P. Baron, Philippe Lucas, Joshua Eades and Olivia Hogue
Consensus article | 08 October 2018
European Headache Federation guideline on idiopathic intracranial hypertension
Jan Hoffmann, Susan P Mollan, Koen Paemeleire, Christian Lampl, Rigmor H Jensen and Alexandra J Sinclair
Research | 18 January 2018
Sphenopalatine ganglion stimulation for cluster headache, results from a large, open-label European registry
Mads Barloese, Anja Petersen, Philipp Stude, Tim Jürgens, Rigmor Højland Jensen and Arne May
Publication years: 2018-2019
Source: Web of Science, data collected: March 2020
European Headache Federation School of Advanced Studies
The European Headache Federation School of Advanced Studies (EHF-SAS) aims to support headache science and offers young EU scientists high quality educational activities to enhance their critical spirit and skills to face headache medicine from a multidisciplinary perspective.
The EHF-SAS covers the richness and diversity of headache medicine fields, including basic science, clinical science, and diagnostic science, and places an emphasis on collaborative projects. The European Headache Federation will support its fellows’ activities allowing them to independently build their own plan sided by the EHF-SAS Scientific Committee.
Editor in Chief (Founding)
Paolo Martelletti, MD,
Department of Clinical and Molecular Medicine
Sapienza University of Rome
Via di Grottarossa 1035
I-00189 Rome, Italy
Assistant to the Editor: Valerio De Angelis
Click here to see the article collections and thematic series that the journal has published in recent years.
The Journal of Headache and Pain has launched In Review, a new option that provides authors with on-demand information on the status of their manuscript, enables them to share their work with funders and their research community, and allows their colleagues to comment and collaborate - all whilst their manuscript is under review.Read more
Call for papers
Editorial Board Spotlight
Dr. Alberto Raggi is a researcher at the Neurological Institute Carlo Besta IRCCS Foundation of Milan (Italy). His main research interests include behavioral treatments for headaches, the evaluation of patient-reported outcome measures and the evaluation of burden of headache disorders based on GBD estimates.
02 September 2019
01 September 2019
Academic education in headache
The demand for a broad, complete and independent education in Headache Disorders has increased over time. The following international Masters courses guarantee a full coverage of this area of clinical medicine.
Annual Journal Metrics
31 days to first decision for reviewed manuscripts only
19 days to first decision for all manuscripts
68 days from submission to acceptance
13 days from acceptance to publication
4.797 - 2-year Impact Factor
4.536 - 5-year Impact Factor
1.164 - Source Normalized Impact per Paper (SNIP)
1.339 - SCImago Journal Rank (SJR)
1418 Altmetric mentions
- ISSN: 1129-2377 (electronic)
- ISSN: 1129-2369 (print)
- Monoclonal Antibodies in Headache
- Neurophysiology of the Migraine Brain
- Societal Impact of Headache
- Neuromodulation in Headache and Facial Pain Management
- Cluster Headache and other Trigeminal Autonomic Cephalgias
- Peripheral Interventional Management in Headache
- Placebos and Nocebos in Headaches
- Gender and Migraine
- Headache and Comorbidities in Childhood and Adolescence
- Comorbidities in Headache Disorders
- Pharmacological Management of Headaches
- Pathophysiology of Headaches